The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
about
CryoEM visualization of an adenovirus capsid-incorporated HIV antigenChimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core proteinMolecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigenImmune tolerance split between hepatitis B virus precore and core proteins.Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.Comparative antigenicity and immunogenicity of hepadnavirus core proteins.Combinatorial approach to hepadnavirus-like particle vaccine designA modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hostsCharacterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody bindingOral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer.Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.A theoretical model for the dynamic structure of hepatitis B nucleocapsidTandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteinsAdvantages to the use of rodent hepadnavirus core proteins as vaccine platformsCryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient.Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.Diversity of core antigen epitopes of hepatitis B virusTobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particlesImmune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopesGene therapy for gastric cancer: is it promising?Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface.Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.Localization of the N terminus of hepatitis B virus capsid protein by peptide-based difference mapping from cryoelectron microscopy.Role of B cells in antigen presentation of the hepatitis B core.Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infectionNative display of complete foreign protein domains on the surface of hepatitis B virus capsids.Interaction of the hepatitis B core antigen and the innate immune system.A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.Use of hepadnavirus core proteins as vaccine platforms.
P2860
Q27335395-B50E4688-8613-48F3-A3BD-D4AB5606515AQ27486069-FF9B81FB-4F71-4857-B719-8C5BE71F5D43Q33811904-5F1089E1-4E34-49F8-895C-8B55AED944B4Q33835018-B85F8E7D-69F9-4428-A412-2075C7EC7E66Q33909134-EC9406BD-F7EB-4B2E-A441-7D6D07979617Q34004151-27B313BF-B587-4075-844F-7BEF1DD565E2Q34092768-B16E26D7-E165-411E-9C71-5E11C403F4C0Q34092773-8F97F400-09D1-482A-8635-95E691E79441Q34261339-C91EE935-F5A1-49D1-9376-6FDEEB235273Q34996753-BFFEFDDB-581A-48B7-A66A-118D47FBA107Q35011130-280601E6-1D5B-4E26-B726-BEADF8EF7C30Q35096289-97A7761B-04F1-4026-923D-46105FF88976Q35556306-7902BD46-A5D0-495D-A51B-A78C2830E72CQ35591846-713038E7-15B1-47EB-8B78-15CEBB4CB069Q35663329-6E5B2E94-F3CB-4E5D-8B1A-1C197465B343Q35680970-C4FAA227-538F-4074-814A-BA478EECA459Q35779035-B383CCFF-6687-40BA-88E0-0AC43B3A5523Q35838564-BD6D663E-D3FD-42F6-A48D-FC0A97095BE6Q35879066-1C9E42CF-2EF4-4F86-BBE4-18DBB8CA5A5EQ35904338-8E4CAD47-3F07-4AEA-B73B-BCEB3966882CQ35978599-9F0AE90B-D2FB-43C9-9D9D-71C0A9537164Q36186712-E934C7F4-EEBF-409A-9E6C-BD68AED993CEQ36203447-9A5155C6-19A2-448D-906E-01DAB6ACB08CQ36262265-9E8D692F-3C93-49E3-9597-B20ED9F40A1EQ36319768-0AD21798-6218-4570-8277-500CF502B29CQ36363602-7D328A44-3166-422E-8F4C-8471C144C14CQ36401504-DC9F36B6-2A98-4069-A916-6A5ABE855F4CQ36632713-8311759C-84F4-40FE-AA78-3ABFB645FEC3Q36634888-B91A156A-34B6-4325-807F-A462233A6BBEQ36685400-2E570EEC-0C78-4CB9-B283-A920098A710EQ36747707-8F020140-A710-4E15-970B-64545EB5763CQ36752843-23DEEBFA-873B-400D-B21F-1148351442A8Q36829085-65A31C82-7DC0-4308-9653-50953BCDE01DQ36856227-863BCFD5-CEC5-447E-87E6-CC47BE6026D1Q36962637-D16E9876-FC97-4FC1-87AF-9183816E7AA8Q37051594-D44ABB51-4B98-4D39-8784-83DC44FC8A4DQ37163704-7D6CD62A-78D6-4879-AB82-B45396F2AE8DQ37200526-3B229A24-8C7F-4BC5-8FFD-786DCCA66C5CQ37571503-7328123D-6F5F-42D3-B9F3-9FC86FDA80D7Q37622906-1D746CA1-C061-42CD-81C5-9F23AEDFA1B1
P2860
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The position of heterologous e ...... termines their immunogenicity.
@ast
The position of heterologous e ...... termines their immunogenicity.
@en
type
label
The position of heterologous e ...... termines their immunogenicity.
@ast
The position of heterologous e ...... termines their immunogenicity.
@en
prefLabel
The position of heterologous e ...... termines their immunogenicity.
@ast
The position of heterologous e ...... termines their immunogenicity.
@en
P2093
P2860
P1433
P1476
The position of heterologous e ...... termines their immunogenicity.
@en
P2093
A M Moriarty
D J Leturcq
D L Peterson
D R Milich
J L Hughes
P2860
P304
P407
P577
1992-01-01T00:00:00Z